Desmopressin Treatment for a Case of Dengue Hemorrhagic Fever/Dengue Shock Syndrome
Open Access
- 1 November 2001
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (9) , 1611-1612
- https://doi.org/10.1086/323013
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- DDAVP IS NOT A PANACEA FOR CHILDREN WITH BLEEDING DISORDERSBritish Journal of Haematology, 2000
- Fluid Replacement in Dengue Shock Syndrome: A Randomized, Double‐Blind Comparison of Four Intravenous‐Fluid RegimensClinical Infectious Diseases, 1999
- Editorial Response: Resuscitation of Patients with Dengue Hemorrhagic Fever/Dengue Shock SyndromeClinical Infectious Diseases, 1999
- Failure of carbazochrome sodium sulfonate (AC-17) to prevent dengue vascular permeability or shock: A randomized, controlled trialThe Journal of Pediatrics, 1997
- Desmopressin (DDAVP) in the Treatment of Bleeding Disorders: The First 20 YearsBlood, 1997
- 1-desamino-8-arginine-vasopressin corrects the hemostatic defects in type 2B von Willebrand's diseaseAmerican Journal of Hematology, 1996